Risk of cardiovascular events and effect on mortality in patients with rheumatoid arthritis

被引：0
|
作者：
Nossent, H [1 ]
机构：
[1] Univ Tromso Hosp, N-9038 Tromso, Norway
来源：
JOURNAL OF RHEUMATOLOGY | 2000年 / 27卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2282 / +
页数：2
相关论文
共 50 条
  • [21] PREDICTORS AND INCIDENCE OF CARDIOVASCULAR EVENTS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Yu, S.
    Pineda, E. D.
    Liao, I
    VALUE IN HEALTH, 2018, 21 : S193 - S193
  • [22] The effect of statin on major adverse cardiovascular events and mortality in patients with rheumatoid arthritis - a systematic review and meta-analysis
    Rahmadi, A. R.
    Pranata, R.
    Raffaello, W. M.
    Yonas, E.
    Ramadhian, M. P.
    Natadikarta, M. R. R.
    Akbar, M. R.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2022, 26 (09) : 3171 - 3178
  • [23] Major adverse cardiovascular events and mortality with opioids versus NSAIDs initiation in patients with rheumatoid arthritis
    Ozen, Gulsen
    Pedro, Sofia
    Michaud, Kaleb
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 (11) : 1487 - 1494
  • [24] Major Adverse Cardiovascular Events and Mortality with Opioids versus NSAIDs Initiation in Patients with Rheumatoid Arthritis
    Ozen, Gulsen
    Pedro, Sofia
    Michaud, Kaleb
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3274 - 3277
  • [25] Cardiovascular morbidity and mortality in patients with rheumatoid arthritis.
    Solomon, DH
    Karlson, EW
    Rimm, EB
    Cannuscio, CC
    Mandl, LA
    Manson, JE
    Stampfer, MJ
    Curhan, GC
    ARTHRITIS AND RHEUMATISM, 2002, 46 (09): : S509 - S509
  • [26] EFFECT OF BIOLOGIC AGENTS ON LIPIDS AND CARDIOVASCULAR RISK IN RHEUMATOID ARTHRITIS PATIENTS
    Pappas, D. A.
    John, A.
    Kremer, J.
    Reed, G.
    Greenberg, J.
    Shewade, A.
    Solomon, D. H.
    Curtis, J. R.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 49 - 49
  • [27] Effect of disease activity on cardiovascular risk factors in patients with rheumatoid arthritis
    Papadakis, J. A.
    Karvounaris, S. T.
    Vrentzos, G.
    Kritikos, H. D.
    Sidiropoulos, P. I.
    Ganotakis, E. S.
    ATHEROSCLEROSIS SUPPLEMENTS, 2007, 8 (01) : 98 - 98
  • [28] CUMULATIVE DISEASE ACTIVITY IN RHEUMATOID ARTHRITIS AND THE RISK OF CARDIOVASCULAR EVENTS
    Solomon, D. H.
    Reed, G. W.
    Kremer, J. M.
    Curtis, J.
    Farkouh, M.
    Harrold, L. P.
    Hochberg, M.
    Tsao, P.
    Greenberg, J. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 637 - 638
  • [29] Cardiovascular risk factors predicting cardiac events are different in patients with rheumatoid arthritis, psoriatic arthritis, and psoriasis
    Cooksey, Roxanne
    Brophy, Sinead
    Kennedy, Jonathan
    Gutierrez, Fabiola Fernandez
    Pickles, Tim
    Davies, Ruth
    Piguet, Vincent
    Choy, Ernest
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2018, 48 (03) : 367 - 373
  • [30] CARDIOVASCULAR EVENTS IN A HIGH RISK MEDICAID POPULATION WITH RHEUMATOID ARTHRITIS
    Shaya, F. T.
    Yan, X.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (01) : 165 - 165
12345